3 transcripts
ZYME
Earnings call transcript
NASDAQ
2024 Q2
1 Aug 24
us an expected runway into the second half of 2027. We may also be able to extend this runway or fund an expanded R&D scope through potential
ZYME
Earnings call transcript
NASDAQ
2024 Q1
2 May 24
results.
We're pleased to be reporting on another busy quarter where we've had a chance to present some really interesting data from our R&D team, which
ZYME
Earnings call transcript
NASDAQ
2023 Q4
6 Mar 24
at Jazz are hosting an R&D Day focused entirely on zanidatamab on March 19, we can hear more of other development plans for zanidatamab. Ahead
- Prev
- 1
- Next